
Not all patients with multiple sclerosis zzso respond equally to available disease zzso agents zzso zzso and reliable criteria are needed to identify zzso and non zzso in order to zzso the zzso Natural history of the disease, clinical evolution and magnetic resonance imaging are the putative indicators to be considered with this respect, but zzso zzso possible zzso markers and pathological or genetic diversity may also represent future additional zzso Clinical recommendations and consensus criteria for defining a zzso response to zzso have been proposed by different international panels of experts, but all need validation in experimental settings to provide solid guidelines for establishing when and how to take action on zzso treatment with zzso 

